COVID-19 Pneumonia during Hydroxychloroquine Treatment of Rheumatoid Arthritis

被引：0

作者：

Gursoy, Canan ^{[1
]}

Tapan, Ozge Oral ^{[2
]}

Dogan, Emrah ^{[3
]}

Togan, Turhan ^{[4
]}

Demirbilek, Semra Gumus ^{[1
]}

机构：

[1] Mugla Sitki Kocman Univ Training & Res Hosp, Dept Anesthesiol & Reanimat, Div Intens Care Unit, Mugla, Turkey

[2] Mugla Sitki Kocman Univ, Dept Lung Dis, Mugla, Turkey

[3] Mugla Sitki Kocman Univ, Dept Radiol, Mugla, Turkey

[4] Mugla Sitki Kocman Univ, Dept Infect Dis, Mugla, Turkey

来源：

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2020年 / 30卷 / 10期

关键词：

Coronavirus; Hydroxychloroquine; Prophylaxis; Rheumatoid arthritis; COVI-19; CHLOROQUINE;

D O I：

10.29271/jcpsp.2020.Supp2.S168

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The recently emerged and novel coronavirus, severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), that caused the current global pandemic was detected for the first time in Turkey in March 2020. While it continues to spread rapidly worldwide, there are still many uncertainties in the prevention and treatment of new coronavirus disease. We report a case of coronavirus disease 2019 (COVID-19) pneumonia in a patient under hydroxychloroquine (HCQ) treatment for rheumatoid arthritis. A 38-year female patient developed severe respiratory distress with SARS-CoV-2 infection and was treated in Intensive Care Unit (ICU). With this report, we aim to discuss the place of HCQ in prophylaxis in the light of the literature with a case presentation of COVID-19 pneumonia under HCQ treatment.

引用

页码：S168 / S170

页数：3

共 6 条

[1] Emerging prophylaxis strategies against COVID-19
Agrawal, Sumita
Goel, Akhil Dhanesh
Gupta, Nitesh
[J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (01)
[2] Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Gao, Jianjun
Tian, Zhenxue
Yang, Xu
[J]. BIOSCIENCE TRENDS, 2020, 14 (01) : 72 - 73
[3] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, Philippe
Lagier, Jean-Christophe
Parola, Philippe
Van Thuan Hoang
Meddeb, Line
Mailhe, Morgane
Doudier, Barbara
Courjon, Johan
Giordanengo, Valerie
Vieira, Vera Esteves
Dupont, Herve Tissot
Honore, Stephane
Colson, Philippe
Chabriere, Eric
La Scola, Bernard
Rolain, Jean-Marc
Brouqui, Philippe
Raoult, Didier
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
[4] Effects of chloroquine on viral infections: an old drug against today's diseases?
Savarino, A
Boelaert, JR
Cassone, A
Majori, G
Cauda, R
[J]. LANCET INFECTIOUS DISEASES, 2003, 3 (11) : 722 - 727
[5] Wang M, 2020, CELL RES, V30, P269, DOI [DOI 10.1038/s41422-020-0282-0, DOI 10.1038/S41422-020-0282-0]
[6] COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression
Zhou, Dan
Dai, Sheng-Ming
Tong, Qiang
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (07) : 1667 - 1670

← 1 →